Blood clotting in pregnancy and the effect of blood thinner
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in your first three months of a normal pregnancy.
- You are 18 years or older.
- You do not have a known bleeding or clotting disorder.
- You have not had a blood clot before.
- You do not take blood-thinning medicine.
- You do not have diabetes, a high body weight (BMI 30 or above), or certain other health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares the best “blood thinner” approach for people who have a new clot in the leg (DVT) or lung (PE) and who already take antiplatelet medicines for heart or blood-vessel prevention. It aims to find an antithrombotic plan that lowers clot risk while managing bleeding risk.
This study looks at what increases the risk of deep vein thrombosis or a lung blood clot (venous thromboembolism) in women who are using hormones. Researchers compare close family members to understand inherited risk and hormone-related triggers, which may help with prevention in the future.
This study looks at pregnancy-related risk for a dangerous blood clot in the leg or lung (venous thromboembolism). It focuses on pregnant people who already have a higher-than-average risk and wants to see how to manage that risk safely.
This study looks at how pregnancy affects blood clots in healthy women. If you qualify, researchers will check your blood's clotting properties to learn more about pregnancy-related changes.
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
This trial compares two blood-thinning medicines (apixaban and enoxaparin) to prevent dangerous blood clots after childbirth. If you are at higher risk for clots but not breastfeeding, you may be able to take part.
Hear when a new Pregnant Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.